Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Curent Deferred Tax Liability: 2012-2013

Historic Curent Deferred Tax Liability for BIO-TECHNE (TECH) over the last 2 years, with Jun 2013 value amounting to $9.9 million.

  • BIO-TECHNE's Curent Deferred Tax Liability fell 30.14% to $9.9 million in Q2 2013 from the same period last year, while for Jun 2013 it was $9.9 million, marking a year-over-year decrease of 30.14%. This contributed to the annual value of $9.9 million for FY2013, which is 30.14% down from last year.
  • Per BIO-TECHNE's latest filing, its Curent Deferred Tax Liability stood at $9.9 million for FY2013, which was down 30.14% from $14.2 million recorded in FY2012.
  • BIO-TECHNE's Curent Deferred Tax Liability's 5-year high stood at $14.2 million during FY2012, with a 5-year trough of $9.9 million in FY2013.
  • In the last 2 years, BIO-TECHNE's Curent Deferred Tax Liability had a median value of $12.1 million in 2012 and averaged $12.1 million.
  • Data for BIO-TECHNE's Curent Deferred Tax Liability shows a maximum YoY plummeted of 30.14% (in 2013) over the last 5 years.
  • BIO-TECHNE's Curent Deferred Tax Liability (Yearly) stood at $14.2 million in 2012, then tumbled by 30.14% to $9.9 million in 2013.